Pro Medicus Stock Current Valuation
| PME Stock | 247.18 2.85 1.17% |
Valuation analysis of Pro Medicus helps investors to measure Pro Medicus' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Pro Medicus' Cash is comparatively stable compared to the past year. Cash And Short Term Investments is likely to gain to about 163.2 M in 2024, despite the fact that Total Cash From Financing Activities is likely to grow to (37.8 M). Fundamental drivers impacting Pro Medicus' valuation include:
Price Book 136.0064 | Enterprise Value 27.9 B | Enterprise Value Ebitda 210.2858 | Price Sales 175.6743 | Forward PE 133.3333 |
Undervalued
Today
Please note that Pro Medicus' price fluctuation is very steady at this time. Calculation of the real value of Pro Medicus is based on 3 months time horizon. Increasing Pro Medicus' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Pro Medicus' intrinsic value may or may not be the same as its current market price of 247.18, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 247.18 | Real 273.3 | Hype 245.73 | Naive 250.88 |
The intrinsic value of Pro Medicus' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Pro Medicus' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Pro Medicus helps investors to forecast how Pro stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pro Medicus more accurately as focusing exclusively on Pro Medicus' fundamentals will not take into account other important factors: Pro Medicus Company Current Valuation Analysis
Pro Medicus' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Pro Medicus Current Valuation | 27.89 B |
Most of Pro Medicus' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pro Medicus is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Pro Medicus has a Current Valuation of 27.89 B. This is much higher than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The current valuation for all Australia stocks is notably lower than that of the firm.
Pro Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pro Medicus' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pro Medicus could also be used in its relative valuation, which is a method of valuing Pro Medicus by comparing valuation metrics of similar companies.Pro Medicus is currently under evaluation in current valuation category among its peers.
Pro Fundamentals
| Return On Equity | 0.51 | ||||
| Return On Asset | 0.31 | ||||
| Profit Margin | 0.51 % | ||||
| Operating Margin | 0.73 % | ||||
| Current Valuation | 27.89 B | ||||
| Shares Outstanding | 104.5 M | ||||
| Shares Owned By Insiders | 49.28 % | ||||
| Shares Owned By Institutions | 14.40 % | ||||
| Price To Book | 136.01 X | ||||
| Price To Sales | 175.67 X | ||||
| Revenue | 161.5 M | ||||
| Gross Profit | 126.79 M | ||||
| EBITDA | 120.76 M | ||||
| Net Income | 82.79 M | ||||
| Total Debt | 2.07 M | ||||
| Book Value Per Share | 1.80 X | ||||
| Cash Flow From Operations | 86.78 M | ||||
| Earnings Per Share | 0.78 X | ||||
| Target Price | 176.21 | ||||
| Beta | 0.54 | ||||
| Market Capitalization | 28.37 B | ||||
| Total Asset | 257.43 M | ||||
| Retained Earnings | 173.36 M | ||||
| Working Capital | 172 M | ||||
| Annual Yield | 0 % | ||||
| Net Asset | 257.43 M | ||||
| Last Dividend Paid | 0.4 |
About Pro Medicus Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pro Medicus's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pro Medicus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pro Medicus based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pro Stock Analysis
When running Pro Medicus' price analysis, check to measure Pro Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pro Medicus is operating at the current time. Most of Pro Medicus' value examination focuses on studying past and present price action to predict the probability of Pro Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pro Medicus' price. Additionally, you may evaluate how the addition of Pro Medicus to your portfolios can decrease your overall portfolio volatility.